Following the news that Moderna’s mRNA COVID-19 vaccine candidate received FDA approval to start Phase II clinical studies; Philipp Rosenbaum, PhD, Infectious Diseases Analyst at GlobalData, a leading data and […]
Following the news that Moderna’s mRNA COVID-19 vaccine candidate received FDA approval to start Phase II clinical studies; Philipp Rosenbaum, PhD, Infectious Diseases Analyst at GlobalData, a leading data and […]